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Abstract
Background: The reflex cough test is useful for detecting silent aspiration, a risk factor for aspiration pneumonia.
However, assessing the risk of aspiration pneumonia requires measuring not only the cough reflex but also cough
strength. Currently, no reflex cough testing device is available that can directly measure reflex cough strength. We
therefore developed a new testing device that can easily and simultaneously measure cough strength and the time
until the cough reflex, and verified whether screening with this new instrument is feasible for evaluating the risk of
aspiration pneumonia.
Methods: This device consists of a special pipe with a double lumen, a nebulizer, and an electronic spirometer. We
used a solution of prescription-grade L-tartaric acid to initiate the cough reflex. The solution was inhaled through a
mouthpiece as a microaerosol produced by an ultrasonic nebulizer. The peak cough flow (PCF) of the induced
cough was measured with the spirometer.
The 70 patients who participated in this study comprised 49 patients without a history of pneumonia (group A), 21
patients with a history of pneumonia (group B), and 10 healthy volunteers (control group).
Results: With the novel device, PCF and time until cough reflex could be measured without adverse effects. The
PCF values were 118.3 ± 64.0 L/min, 47.7 ± 38.5 L/min, and 254.9 ± 83.8 L/min in group A, group B, and the control
group, respectively. The PCF of group B was significantly lower than that of group A and the control group (p < 0.
0001), while that of group B was significantly lower than that of the control group (p < 0.0001). The time until the
cough reflex was 4.2 ± 5.9 s, 7.0 ± 7.0 s, and 1 s in group A, group B, and the control group, respectively. This
duration was significantly longer for groups A and B than for the control group (A: p < 0.001, B: p < 0.001), but there
was no significant difference between groups A and B (p = 0.0907).
Conclusion: Our newly developed device can easily and simultaneously measure the time until the cough reflex
and the strength of involuntary coughs for assessment of patients at risk of aspiration pneumonia.
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Background
Pneumonia is a common event after strokes and is asso-
ciated with morbidity and mortality in stroke patients. It
reportedly occurs in one-third of all stroke victims and
is the most common respiratory complication in this
population [1]. The risk factors for aspiration pneumo-
nia include silent aspiration caused by old age and
neuromuscular disorders, but not cerebral stroke. The
identification of patients who are at risk of developing
pneumonia is thus important in terms of morbidity and
mortality as well as cost of care.
The videofluorographic swallowing study (VFSS) is the
definitive test to identify aspiration and other swallowing
abnormalities [2]. Previous studies have shown that aspir-
ation observed on VFSS indicates a risk of developing
aspiration pneumonia. The laryngeal cough reflex protects
the laryngeal aditus from significant aspiration of food,
fluids, and secretions, and reduces the risk of aspiration
pneumonia [3, 4]. However, VFSS is not routinely used to
assess the laryngeal cough reflex. Dysphagia and the cough
reflex are separate physiologic and neurologic issues and
should therefore be independently assessed. Furthermore,
several screening tests, including the water test, food test,
and saliva swallowing test, cannot detect silent aspiration
in patients without a cough reflex.
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Previous research has suggested that adding a cough
sensitivity test to clinical swallowing evaluations has the
potential to reduce the risk of pneumonia after stroke. A
clinical guideline for cough assessment produced in
2007 by the European Respiratory Society Task Force
highlighted the lack of standardization of cough testing
protocols using cough-stimulating agents [5]. In the re-
flex cough test (RCT) the patient inhales citric acid and
tartaric acid from low to high concentrations and the
presence of a cough is assessed. Studies have shown that
the inhalation of tartaric acid stimulates coughs in
normal subjects [3, 6, 7], and that the RCT is useful for
the detection of silent aspiration [8, 9]. In these studies,
nebulized tartaric acid was shown to be safe and did not
produce systemic or adverse side effects. However, the
RCT results were evaluated in terms of the presence and
number of coughs, but not cough strength. Voluntary
cough strength can be measured with a spirometer, but
up to this point no devices have been able to measure
involuntary cough strength as part of the RCT. Another
drawback of the RCT is the subjective evaluation of
cough strength by the examiner, because it is important
to determine whether the cough generated by the stimu-
lating agent is effective, and whether the subject can
cough up secretions.
To overcome these shortcomings, we developed a de-
vice to quantify the cough reflex. This paper describes
the use of an objective examination system, called the
modified RCT (mRCT), to quantify both a tartaric-acid-
stimulated involuntary cough and the time until the
cough reflex. The study also investigated whether
screening with this new instrument would be feasible for
evaluating the risk of aspiration pneumonia.
Methods
Apparatus for the mRCT
The new mRCT device consists of a mouthpiece, tube,
filter, spirometer IH-105 (Chest M.I., Inc., Tokyo, Japan),
and ultrasound nebulizer UN-703 (Alfresa Pharma Cor-
poration, Osaka, Japan). The tube was designed as a
double pipe with 10 holes between the inner and outer
pipes, which are made of rigid plastic material. We
designed this instrument and ordered the resin from a
resin-processing company. A corrugated tube is con-
nected from the ultrasound nebulizer to the outer pipe,
and the spirometer sensor is attached to the inner pipe.
The microaerosol emitted by the ultrasound nebulizer
fills the outer pipe, and is administered to the oral and
airway epithelia through the holes and mouthpiece. The
cough then passes through the inner pipe to the spirom-
eter sensor, which shows the peak cough flow (PCF)
value on the monitor (Fig. 1). The device can thus easily
quantify the flow of an involuntary cough.
mRCT
The RCT stimulates cough receptors in the vestibule
of the larynx and initiates the laryngeal cough reflex
[3, 6, 10–12]. The mRCT in this study used a 20%
solution of prescription-grade l-tartaric acid dissolved
in 2 mL of sterile normal saline [8]. The solution was
placed in an ultrasound nebulizer and inhaled as a
microaerosol. During the inhalation, the subject’s nose
was pinched closed. The mRCT was administered by
either a speech therapist or an otorhinolaryngologist
at the bedside or at the ENT clinic of Tottori
University Hospital. Subjects were instructed to ex-
hale, to position the mouthpiece appropriately, and
then to inhale sharply and deeply and to hold their
breath after inhaling. To prevent leakage around the
mouthpiece, subjects were asked use their lips to pull
it toward the back of the throat. The examiner held
the device to prevent it from falling. The mRCT was
considered to be complete when either a cough re-
sponse was elicited or the subject failed to respond
within 30 s after the start of the inhalation. The spir-
ometer showed the reflex cough strength as the PCF
on the display. The time from the start of tartaric
acid administration until the cough reflex was defined
as the time until cough reflex. Both this time and the
PCF were recorded. If there was no cough reflex, the
recorded PCF value was 0 ml/min. For each subject
Fig. 1 Schematic diagram of modified reflex cough test using our
new equipment. The new cough reflex testing device consists of a
mouthpiece, tube, filter, spirometer (gray arrow), and ultrasound
nebulizer (white arrow). The tube is designed as a double pipe (black
arrow) with ten holes between the inner and outer pipes. A
corrugated tube (white triangle) from the ultrasound nebulizer is
connected to the outer pipe, and the spirometer sensor is attached
to the inner pipe (black triangle). The microaerosol emitted from the
ultrasound nebulizer fills the outer pipe, and is administered to the
oral and airway epithelia through the holes and mouthpiece. The
cough then passes through the inner pipe to the spirometer sensor
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this test was performed once per day to prevent test-
induced changes to the sensitivity threshold of the
airway mucosa from influencing a subsequent test. If
the examination was suboptimal, it was repeated on
another day. Furthermore, patients who had experi-
enced aspiration pneumonia were examined after they
had completely recovered.
To prevent infection, the double pipe was soaked in
glutaral and rinsed under running water. Furthermore,
the filter, corrugated tube, and mouthpiece were all
disposable.
Statistical analysis
All values are presented as mean ± SD. For statistical
analyses, the Mann-Whitney U test was used to evaluate
to evaluated the differences of the PCF between different
groups of patients, and the log-rank test was used to as-
sess the time until the cough reflex. The Mann-Whitney
U test was used to statistically analyze the differences in
age and BMI between each group.
Result
Patients
Between April 2013 and March 2014, 70 patients partici-
pated in our clinical trial of the mRCT. All had dyspha-
gia as a subjective symptom and were referred for an
examination of swallowing function due to neuromuscu-
lar disease, cerebral stroke, or aspiration pneumonia.
The Tottori University institutional review board
approved the use of the mRCT with tartaric acid for the
screening of silent aspiration. Informed consent was ob-
tained from all patients. VFSS, video endoscopy, and
manometery, but not the mRCT, were performed for the
evaluation of swallowing function. Patients with trismus
or disordered consciousness were excluded from the
trial. Before the mRCT, we determined patients’ past his-
tory of pneumonia by asking them directly and checking
their medical records. The 49 patients without previous
pneumonia were classified as group A, and 21 with such
a history comprised group B. Group A consisted of 36
males and 13 females with an average age of 69.7 ±
11.0 years and an average body mass Index (BMI) of
20.7 ± 3.8. Group B consisted of 11 males and 10 females
with an average age of 71.7 ± 17.0 years and an average
BMI of 18.2 ± 3.3. Additionally, 10 healthy volunteers
participated in the clinical study as the control group;
these individuals had an average age of 36.6 ± 19.9 and
an average BMI of 20.8 ± 1.4. Although we found no sig-
nificant difference between groups A and B in terms of
age, they differed significantly in terms of BMI. The
healthy controls were significantly younger than the two
disease groups. The primary diseases of all patients are
shown in Table 1. Two years after the study concluded,
4 patients (8.1%) in group A developed aspiration
pneumonia. In contrast, 14 patients (66.7%) in group B
developed aspiration pneumonia, and 4 (19.0%) under-
went laryngeal separation surgery. VFSS identified
dysphasia in 29 patients in group A (13 aspiration, 10
penetration, 6 pooling in the pharynx) and in 17 patients
in group B (14 aspiration, 2 penetration, 1 pooling in the
pharynx). All patients completed the mRCT without any
adverse effects or complications resulting from its
administration. The mRCT was performed as previously
described and the PCF and the time until the cough
reflex were recorded.
mRCT
This system could measure the PCF and time until
cough reflex without any adverse effects. The test took
less than 30 s and the preparation time was less than
2 min. The test was performed by one examiner without
assistance. Thirteen patients were evaluated in the su-
pine position and 57 patients and the 10 healthy volun-
teers were evaluated in the sitting position. All three
groups of patients were included in the analysis.
Table 1 Primary disease of all patients
Group A Group B
Parkinson disease 8 Parkinson disease 5
hypopharyngeal cancer 6 cerebral infarction 3
cerebral infarction 5 multiple system atrophy 3
multiple system atrophy 4 amyotrophic lateral sclerosis 2
amyotrophic lateral sclerosis 2 chordoma 1
laryngeal cancer 2 dementia 1
oropharyngeal cancer 2 encephalomyelitis 1
progressive supranuclear palsy 2 COPD 1
Wallenberg syndrome 2 Gaucher disease 1
Alzheimer 1 myasthenia gravis 1
aortic aneurysm 1 pneumonia 1
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PCF
During the mRCT, one patient exhibited no cough reflex
within 30 s after the start of inhalation. The PCF of group
A was 118.3 ± 64.0 L/min, that of group B was 47.7 ±
38.5 L/min, and that of the control group was 254.9 ±
83.8 L/min. The PCF of group B was significantly lower
than that of group A and the control group (p < 0.0001),
while that of group B was significantly lower than that of
the control group (p < 0.0001) (Fig. 2). The PCF values of
patients with and without development of aspiration
pneumonia after the study concluded were 0.93 ± 0.76 and
1.87 ± 1.11, respectively, which was significantly different
(P < 0.0002). In terms of the correlation between VFSS
and PCF results, the PCF of patients with normal VFSS
finding was 1.7 +/− 1.2 L/min, and that of patients with
dysphagia was 1.5 +/− 1.0 L/min. There was no significant
difference between patients with and without dysphagia.
Time until cough reflex
The time until the cough reflex was 4.2 ± 5.9 s in group A,
7.0 ± 7.0 s in group B, and 1 s in the control group. The
time until the cough reflex was significantly longer in
groups A and B than in the control group (A: p < 0.001; B:
p < 0.001), but there was no significant difference between
groups A and B (p = 0.0907) (Fig. 3).
Discussion
Silent aspiration is defined as aspiration without coughing
or other obvious distress, and has been linked to an
increased prevalence of pneumonia and mortality [13, 14].
The risk of pneumonia was found to be increased 10-fold
in patients with profound aspiration and 13-fold in those
with silent aspiration [15]. However, patients with silent
aspiration have no symptoms, including coughing, and
dysphagia is therefore more likely to be identified late in
disease development. Early identification of silent aspir-
ation and prevention of pneumonia are thus essential in
view of the high mortality associated with these
conditions.
VFSS is the definitive test for identification of aspir-
ation and other swallowing abnormalities, but it cannot
be performed at every institution. This makes swallow-
ing screening tests essential. These tests consist of the
water screening test, food test, saliva swallowing test,
and RCT. Tohara et al. reported that the water swallow-
ing test (3 ml of water) and the food test (4 g of pud-
ding) had a sensitivity of 90% and specificity of 56% [16],
while Nishiwaki et al. found that the sensitivity of the
saliva-swallowing test was 28% and the specificity was
76% [17]. However, since patients with silent aspiration
have difficulty coughing, a simple screening test cannot
be used to detect their condition in the clinical setting.
The RCT is reportedly the method of choice for detect-
ing silent aspiration, and uses citric acid and tartaric acid
to trigger the cough [9].
The RCT using citric acid demonstrated a diminished
cough reflex in patients with aspiration pneumonia [9].
An impaired cough reflex may play a role in the patho-
genesis of aspiration pneumonia, and it was suggested
that the early detection of a diminished cough reflex in
patients with a predisposition to aspiration helped pre-
vent aspiration pneumonia [9]. A previous study re-
ported that the RCT fail rate for patient cohorts with
suspected dysphagia was 25% for VFSS and 23% for fiber
optic endoscopic evaluation of swallowing [18].
However, the RCT using citric acid takes a long time,
and the procedure and decision criteria are complicated,
thus making it difficult to use this test to examine pa-
tients in debilitated condition. The RCT using tartaric
acid is an alternative method that is simple and quick
and can thus be more appropriate for such patients.
Addington et al. reported that using the tartaric acid
RCT after a neurological event was essential for deter-
mining the appropriate clinical treatment plan for pre-
scription of food, fluids, and medications. Moreover, the
Fig. 2 Peak cough flow of controls and patients with and without
AP. The PCF of group B (with AP) was significantly lower than that of
group A (without AP) and the control group, while that of group A
was significantly lower than that of the control group. (* p < 0.0001)
Fig. 3 Time until cough reflex in controls and patients with and
without AP. The time until cough reflex was significantly longer in
groups A (without AP) and B (with AP) than in the control group (A:
p < 0.001, B: p < 0.001), but there was no significant difference
between groups A and B (p = 0.0907)
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RCT helps to stratify pneumonia risk and improves out-
comes by reducing morbidity, mortality, and cost [8].
One major problem with the conventional RCT method
is that cough strength is subjectively evaluated by the
examiner, thus results may differ among providers.
We developed an objective measuring device to simul-
taneously quantify cough strength and the time until the
cough reflex occurs. This equipment is a novel device
that can assess the relationship between aspiration pneu-
monia and PCF, the latter measured with the RCT using
tartaric acid. The merits of our device are that it can
quantify the triggered involuntary cough and measure
the time until the cough reflex; there are no adverse re-
actions, and the examination takes only a short time.
An electromyography-based RCT system that can also
evaluate the risk of aspiration pneumonia was patented
in the United States in 2004 (https://www.google.com/
patients/us20040181161). However, the use of electro-
myography to measure cough strength is an indirect
approach. If patients have upper respiratory tract condi-
tions that impair effective cough expulsion, such as la-
ryngeal paralysis and head and neck cancer,
electromyography cannot accurately measure cough
strength. In contrast, our device is able to directly evalu-
ate cough strength.
The results of our screening test showed that there
was a significant difference in the PCF of patients with
and without a history of pneumonia. Thus, the PCF
value may indicate the risk of pneumonia and suggests
that our equipment permits objective quantification and
evaluation.
Hammand et al. reported that peak flow during the in-
spiration phase and the sound pressure level of volun-
tary cough was significantly impaired in severe
aspirators as compared with non-aspirators [19]. Beck et
al. evaluated voluntary cough and found that in patients
with severe respiratory muscle insufficiency and a PCF
of less than 160 L/min, decannulation was unsuccessful
due to difficulty in keeping the airway clear after extuba-
tion and decannulation [20]. Lasserson et al. reported
that PCF of involuntary cough was less than that of vol-
untary cough, explaining that this was related to differ-
ences between the two types of cough in terms of the
functional organization of muscle activation [21]. Tar-
taric acid is thought to induce coughing by stimulating
irritant receptors and C-fiber receptors [5]. Unlike a vol-
untary cough, the stimulus that induces an involuntary
cough is delivered to the cough center, located in the
nucleus tractus solitarius of the medulla oblongata, via
sensory nerves ending through the vagus nerve afferent
pathway sensory nerve ending, and not under cerebral
cortex control. As explained above, quantification and
evaluation of involuntary cough are indispensable for the
assessment of aspiration. Since the novel measurement
system developed in this study overcomes various diffi-
culties and can measure the PCF of involuntary cough, it
can provide a realistic assessment of the risk of aspir-
ation pneumonia.
Our device can also measure the sensitivity threshold
of the airway mucosa. Moreover, its use showed that
there was a significant difference in the time until cough
reflex between normal subjects and patients with
dysphagia, making it possible to determine the relation-
ship between the time until cough reflex and dysphagia.
There was no significant difference in the time until
cough reflex between patients with and without a previ-
ous history of pneumonia. There are actually two dis-
tinct types of reflexive, non-voluntary cough with
different underlying neurological mechanisms: a primary
cough reflex occurring at the level of the vocal folds,
often referred to as the laryngeal cough reflex, and a
deeper tracheobronchial cough reflex that tends to be
delayed and less productive [22]. The receptors in the
larynx and trachea are extremely sensitive to mechanical
stimuli, with very rapid adaptation. Deeper into the air-
ways, the receptors become more chemosensitive and
less mechanosensitive. The aerosol can thus penetrate
deeper into the lung and stimulate the more chemosen-
sitive cough receptors there. In other words, the chemo-
sensitive stimulation of the tartaric acid aerosol differs
from the mechanosensitive stimulation of food and sal-
iva. Thus, the time until the cough reflex may not be ac-
curately assessed by mechanosensitive stimulation.
VFSS is the gold standard for evaluating swallowing.
However, VFSS showed no significant differences in peak
flow between patients with and without dysphagia. Since
VFSS evaluates swallowing dynamics, it is suggested that
there was no relationship between swallowing dynamics
and cough strength, and the cough reflex test should be
used in combination with VFSS to compensate for limi-
tations of each test.
There are certain limitations to our study. First,
patients with trismus or disordered consciousness were
excluded from this study because the device was not
suitable in these populations. Further development of
our device is required to generalize its use. Second, PCF
and time until cough reflex were retrospectively evalu-
ated based on past history of aspiration pneumonia, and
no prospective cases of aspiration pneumonia were stud-
ied in this report. In the near future, we plan to pro-
spectively evaluate the risk of aspiration pneumonia
using our novel device. Third, since differences in cough
reflex may be age related rather than disease specific,
further work will need to be undertaken in the future
with age-matched controls to ensure this is not the case.
Future studies of the diagnostic accuracy of this device
will ideally recruit participants using a single-gate design
in order to more accurately identify the test
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characteristics that are applicable to clinical practice. It
has been demonstrated that increasing age contributes
far more to reduced local sensitivity than do neuromus-
cular disorders, which explains the higher prevalence of
dysphagia in older patients [23]. Moreover, several stud-
ies have shown that silent aspiration is associated with
advancing age [24–26]. This means that there are many
patients at risk of silent aspiration, and if a method
could easily assess this risk it would be in great demand.
Furthermore, if our method becomes more prevalent, it
will make it easier for patients at risk of silent aspiration
to gain access to specialized medical care. We would like
to miniaturize and simplify our device to make it avail-
able not only to medical staff but to any qualified
personnel.
Conclusion
Our newly developed device can easily and simultaneously
measure the time until the cough reflex and the power of
involuntary cough, without any adverse effects, for assess-
ment of patients at risk of aspiration pneumonia. This
constitutes the first system that can directly measure the
strength of involuntary cough.
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